Clearmind Medicine Inc. (CMND)
NASDAQ: CMND · Real-Time Price · USD
0.9880
+0.0215 (2.22%)
At close: May 12, 2025, 4:00 PM
1.000
+0.012 (1.21%)
After-hours: May 12, 2025, 7:25 PM EDT
Clearmind Medicine Market Cap
Clearmind Medicine has a market cap or net worth of $5.07 million as of May 12, 2025. Its market cap has increased by 28.55% in one year.
Market Cap
5.07M
Enterprise Value
-796.75K
1-Year Change
28.55%
Ranking
Category
Stock Price
$0.99
Market Cap Chart
Since August 16, 2021, Clearmind Medicine's market cap has decreased from $26.17M to $5.07M, a decrease of -80.62%. That is a compound annual growth rate of -35.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 4.96M | -11.34% |
| Dec 31, 2024 | 5.60M | 17.66% |
| Dec 29, 2023 | 4.76M | -39.13% |
| Dec 30, 2022 | 7.82M | -59.16% |
| Dec 27, 2021 | 19.14M | -26.88% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |